Related Research Articles
The Temerty Faculty of Medicine is the medical school of the University of Toronto. Founded in 1843,the faculty is based in Downtown Toronto and is one of Canada's oldest institutions of medical studies,being known for the discovery of insulin,stem cells and the site of the first single and double lung transplants in the world.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,Denmark,with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 25% of its shares and a relative majority (45%) of its voting shares.
Ricky Kanee Schachter,FRCP(C),CM was a dermatologist who practiced in the Toronto area,and was invested as a Member of the Order of Canada in 1998,as "a researcher,teacher,administrator and healer,whose work in the areas of skin cancer and psoriasis has improved the lives of her patients,and inspired fellow researchers across Canada."
Women's College Hospital is a teaching hospital in downtown Toronto,Ontario,Canada. It is located at the north end of Hospital Row,a section of University Avenue where several major hospitals are located. It currently functions as an independent ambulatory care hospital. The Chief of Staff is Dr. Sheila Laredo and the physician-in-chief is Dr. Paula Harvey.
Carl Ronald Kahn is an American physician and scientist,best known for his work with insulin receptors and insulin resistance in diabetes and obesity. He is the Chief Academic Officer at Joslin Diabetes Center,the Mary K. Iacocca Professor of Medicine at Harvard Medical School and a member of the National Academy of Sciences since 1999.
Shashank R. Joshi is an Indian endocrinologist,diabetologist and medical researcher,considered by many as one of the prominent practitioners of the trade in India. He was honoured by the Government of India,in 2014,by bestowing on him the Padma Shri,the fourth highest civilian award,for his services to the field of medicine. He is a part of the COVID-19 Task Force for the state of Maharashtra,India.
Daniel Joshua Drucker is a Canadian endocrinologist. A Fellow of the Royal Society,he is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute,Mount Sinai Hospital,Toronto. He is known for his research into intestinal hormones and their use in the treatment of diabetes and other metabolic diseases.
Semaglutide,sold under the brand names Ozempic,Wegovy and Rybelsus,is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management,developed by Novo Nordisk in 2012. It is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1),modified with a side chain. It can be administered by subcutaneous injection or taken orally.
Avideh Nazeri is an Iranian endocrinologist and Director of Clinical,Medical and Regulatory for Novo Nordisk UK and Ireland.
David Dunger was a British paediatric endocrinologist and chair of paediatrics at the University of Cambridge. Dunger was most notable for research into three areas,pathogenesis of type 1 diabetes and its complications,perinatal origins of risk for obesity and type 2 diabetes along with experimental medicine.
Beverley E. Pearson Murphy, MD,was a Canadian endocrinologist and professor emeritus at McGill University.
Helen Bell Milburn was a Canadian radiologist. She was on the staff of the Department of Radiology at Toronto’s Women's College Hospital from 1923–1954 and the Chairman of the hospital’s Breast Cancer Research Committee.
Sophie Jamal is a Canadian endocrinologist and former osteoporosis researcher who was at the centre of a scientific misconduct case in the mid-to-late 2010s. Jamal published a high-profile paper suggesting that the heart medication nitroglycerin was a treatment for osteoporosis,and was later demonstrated to have misrepresented her results. She received a lifetime ban from receiving funding from the Canadian Institutes of Health Research and was named directly in their disclosure report,becoming the first person mentioned by name by the institute for scientific misconduct. Jamal was later stripped of her medical license for two years,regaining it in a controversial 3–2 decision.
Henrietta Elizabeth Banting or “Lady Banting”was a Canadian physician and the second wife of Sir Frederick Banting. Banting was the Director of Women's College Hospital's Cancer Detection Clinic from 1958-1971. While working at the Cancer Detection Clinic,she conducted a research study on mammography to measure its effectiveness as a diagnostic tool for breast cancer.
Rulan S. Parekh is an American-Canadian clinician-scientist and nephrologist. She is the vice president of research,education and innovation at Women's College Hospital and former senior scientist in Child Health Evaluative Sciences and Associate Chief of Clinical Research at SickKids.
Simone Natalie Vigod is a Canadian scientist,Head of the Department of Psychiatry at Women's College Hospital and Professor in the Department of Psychiatry at the University of Toronto in Toronto,Ontario,Canada. She focuses her research on perinatal mood disorders and has conducted some of the largest studies worldwide on maternal mental illness around the time of pregnancy.
Kelly A. Metcalfe is a Canadian scientist and a professor at the University of Toronto and at Women's College Hospital. Her work's focus is on understanding the clinical and psychosocial implications of genetic testing for BRCA gene mutations in women,men and their families.
Gillian Alexandra Hawker is a Canadian clinician-scientist. She is a Professor of Medicine at the University of Toronto and Sir John and Lady Eaton Professor and Chair of Medicine at Women's College Hospital. Hawker's research focuses on causes and treatments for osteoarthritis.
Wiebke Arlt is a German endocrinologist and William Withering Chair of Medicine at the University of Birmingham. She specialises in adrenal disease and disorders of sex development.
Catharine Isobel Whiteside,CM,FRCPC,FCAHS is a Canadian physician and medical researcher. She is Director,Strategic Partnerships of Diabetes Action Canada and Chair of the board of the Banting Research Foundation. Whiteside is the former Dean of the Faculty of Medicine at the University of Toronto.
References
- 1 2 3 Treleaven, Sarah (November 1, 2017). "How Dr. Lorraine Lipscombe is creating better care for women with diabetes". Women of Influence. Archived from the original on 2022-02-11. Retrieved February 11, 2022.
- ↑ "LORRAINE LIPSCOMBE, MD, MSC, FRCPC". Women's College Hospital. Archived from the original on 2022-02-11. Retrieved February 11, 2022.
- ↑ "Starting diabetes prevention during pregnancy". Diabetes Canada. October 1, 2021. Archived from the original on 2022-02-11. Retrieved February 11, 2022.
- ↑ "WCRI receives more than $2.4 million in new research funding". Women's College Hospital. June 7, 2017. Archived from the original on 2022-02-11. Retrieved February 11, 2022.
- ↑ "Research examines healthcare experience for cancer patients who also have diabetes". OICR. November 22, 2016. Archived from the original on 2022-02-11. Retrieved February 11, 2022.
- ↑ Eligh, Blake (June 18, 2021). "U of T endocrinologist Lorraine Lipscombe to lead 'powerhouse' diabetes research network". University of Toronto. Archived from the original on 2022-02-11. Retrieved February 11, 2022.
| Authority control: Academics |
|---|
